Top 10 Small Cap Stocks with Highest Upside: IVAN, SA, COCO, LTXC, ALTH, CHC, AOI, CAK, RAD, ISPH (Aug 19, 2010)

Below are the top 10 Small Cap stocks with highest upside potential, based on the difference between current price and Wall Street analysts' average target price. One Chinese company (CHC) is on the list.

Ivanhoe Energy Inc. (USA) (NASDAQ:IVAN) has the 1st highest upside potential in this segment of the market. Its upside is 165.2%. Its consensus target price is $4.35 based on the average of all estimates. Seabridge Gold, Inc. (USA) (AMEX:SA) has the 2nd highest upside potential in this segment of the market. Its upside is 163.7%. Its consensus target price is $79.16 based on the average of all estimates. Corinthian Colleges, Inc. (NASDAQ:COCO) has the 3rd highest upside potential in this segment of the market. Its upside is 144.4%. Its consensus target price is $13.00 based on the average of all estimates. LTX-Credence Corporation (NASDAQ:LTXC) has the 4th highest upside potential in this segment of the market. Its upside is 139.8%. Its consensus target price is $5.30 based on the average of all estimates. Allos Therapeutics, Inc. (NASDAQ:ALTH) has the 5th highest upside potential in this segment of the market. Its upside is 130.5%. Its consensus target price is $10.17 based on the average of all estimates.

China Hydroelectric Corporation (NYSE:CHC) has the 6th highest upside potential in this segment of the market. Its upside is 126.1%. Its consensus target price is $13.50 based on the average of all estimates. Alliance One International, Inc. (NYSE:AOI) has the 7th highest upside potential in this segment of the market. Its upside is 125.4%. Its consensus target price is $8.00 based on the average of all estimates. CAMAC Energy Inc (AMEX:CAK) has the 8th highest upside potential in this segment of the market. Its upside is 122.2%. Its consensus target price is $7.00 based on the average of all estimates. Rite Aid Corporation (NYSE:RAD) has the 9th highest upside potential in this segment of the market. Its upside is 119.8%. Its consensus target price is $2.15 based on the average of all estimates. Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) has the 10th highest upside potential in this segment of the market. Its upside is 115.7%. Its consensus target price is $10.33 based on the average of all estimates.